De Montfort University and Ithaka Life Sciences launch drug discovery spin out.

UK-based De Montfort University (DMU) has unveiled plans to launch a new drug discovery company with life sciences commercialisation company Ithaka Life Sciences to market technology designed to streamline the development of drugs and medicines.

Called CYP Design (CDL), the UK-based spin out will incorporate new technology, CYPs, to provide new products and services originally developed at and licenced from DMU. CYPs, which are responsible for the metabolism of drugs in people, currently need dry ice to be shipped and expensive cooling equipment to use. The latest DMU innovation allows for the CYPs to be handled at room temperature.

“The development of new drugs can be very time-consuming and costly. It can take up to 14 years from the initial idea and cost hundreds of millions of pounds. Thousands of potential new drugs are tested initially for every one successfully brought to market,” said Bob Chaudhuri, a professor at DMU.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?